Fluoride Treatment and Risk of Fracture In Osteoporosis Patients

Alshikhi, Sara Almabrouk (2018-03-14)

Osteoporosis is common systemic skeletal disease characterized by low bone mass and microarchitectural deterioration of bone tissue, leading to enhanced bone fragility and a consequent increase in fracture risk” • More common in postmenopausal Sodium fluoride stimulates bone formation and increases cancellous-bone mass Sodium fluoride (NaF) was currently the only pharmacological agent capable of stimulating bone formation through a direct effect on the osteoblast

Other

حاويات:
Attribution 3.0 United States
Except where otherwise noted, this item's license is described as Attribution 3.0 United States